|
|||||
|
|
Definite regression of cutaneous melanoma metastases upon addition of topical contact sensitizer diphencyprone to immune checkpoint inhibitor treatment |
|
| Authors: | Nicholas Gulati Richard D. Carvajal Michael A. Postow Jedd D. Wolchok James G. Krueger |
| Affiliation: | 1. Laboratory for Investigative Dermatology, The Rockefeller University, New York, NY, USA;2. The Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY, USA;3. Melanoma and Immunotherapeutics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA;4. Weill Cornell Medical College, New York, NY, USA |
| Abstract: | |
| Keywords: | diphencyprone immunotherapy melanoma pembrolizumab |